Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford University, School of Medicine, Stanford, Calif.
Division of Thoracic Surgery, Department of Surgery, David Geffen School of Medicine at UCLA and West Los Angeles VA Medical Center, Los Angeles, Calif.
J Thorac Cardiovasc Surg. 2014 Jul;148(1):30-5. doi: 10.1016/j.jtcvs.2014.03.011. Epub 2014 Mar 14.
To date, reported surgical morbidity and mortality for pleurectomy/decortication and extrapleural pneumonectomy performed for malignant pleural mesothelioma primarily represent the experience of a few specialized centers. For comparison, we examined early outcomes of pleurectomy/decortication and extrapleural pneumonectomy from a broader group of centers/surgeons participating in the Society of Thoracic Surgeons-General Thoracic Database.
All patients in the Society of Thoracic Surgeons-General Thoracic Database (version 2.081, representing 2009-2011) who underwent pleurectomy/decortication or extrapleural pneumonectomy for malignant pleural mesothelioma were identified. Patient characteristics, morbidity, mortality, center volume, and procedure were examined using univariable and multivariable analyses.
A total of 225 patients underwent pleurectomy/decortication (n = 130) or extrapleural pneumonectomy (n = 95) for malignant pleural mesothelioma at 48 centers. Higher volumes of procedures (≥5/y) were performed at 3 pleurectomy/decortication and 2 extrapleural pneumonectomy centers. Patient characteristics were statistically equivalent between pleurectomy/decortication and extrapleural pneumonectomy groups, except those undergoing extrapleural pneumonectomy were younger (63.2 ± 7.8 years vs 68.3 ± 9.5 years; P < .001) and more likely to have received preoperative chemotherapy (30.1% vs 17.8%; P = .036). Major morbidity was greater after extrapleural pneumonectomy, including acute respiratory distress syndrome (8.4% vs 0.8%; P = .005), reintubation (14.7% vs 2.3%; P = .001), unexpected reoperation (9.5% vs 1.5%; P = .01), and sepsis (4.2% vs 0%; P = .03), as was mortality (10.5% vs 3.1%; P = .03). Multivariate analyses revealed that extrapleural pneumonectomy was an independent predictor of major morbidity or mortality (odds ratio, 6.51; P = .001). Compared with high-volume centers, increased acute respiratory distress syndrome was seen in low-volume centers performing extrapleural pneumonectomy (0% vs 12.5%; P = .05).
Extrapleural pneumonectomy is associated with greater morbidity and mortality compared with pleurectomy/decortication when performed by participating surgeons of the Society of Thoracic Surgeons-General Thoracic Database. Effects of center volume require further study.
迄今为止,报道的胸膜切除术/剥脱术和胸膜外全肺切除术治疗恶性胸膜间皮瘤的手术发病率和死亡率主要代表了少数几个专业中心的经验。为了进行比较,我们从参与胸外科医师学会普通胸外科数据库的更多中心/外科医生中检查了胸膜切除术/剥脱术和胸膜外全肺切除术的早期结果。
在胸外科医师学会普通胸外科数据库(版本 2.081,代表 2009-2011 年)中,确定了所有接受胸膜切除术/剥脱术或胸膜外全肺切除术治疗恶性胸膜间皮瘤的患者。使用单变量和多变量分析检查患者特征、发病率、死亡率、中心量和手术。
共有 225 名患者在 48 个中心接受了胸膜切除术/剥脱术(n=130)或胸膜外全肺切除术(n=95)治疗恶性胸膜间皮瘤。在 3 个胸膜切除术/剥脱术和 2 个胸膜外全肺切除术中心进行了更高数量的手术(≥5/年)。胸膜切除术/剥脱术组和胸膜外全肺切除术组患者的特征在统计学上是相等的,除了接受胸膜外全肺切除术的患者年龄较小(63.2±7.8 岁比 68.3±9.5 岁;P<.001)和更有可能接受术前化疗(30.1%比 17.8%;P=.036)。胸膜外全肺切除术的主要发病率更高,包括急性呼吸窘迫综合征(8.4%比 0.8%;P=.005)、再插管(14.7%比 2.3%;P=.001)、意外再次手术(9.5%比 1.5%;P=.01)和败血症(4.2%比 0%;P=.03),死亡率也更高(10.5%比 3.1%;P=.03)。多变量分析显示,胸膜外全肺切除术是主要发病率或死亡率的独立预测因素(比值比,6.51;P=.001)。与高容量中心相比,在进行胸膜外全肺切除术的低容量中心,急性呼吸窘迫综合征的发生率更高(0%比 12.5%;P=.05)。
与胸膜切除术/剥脱术相比,胸外科医师学会普通胸外科数据库的外科医生进行胸膜外全肺切除术与更高的发病率和死亡率相关。中心量的影响需要进一步研究。